SCHEMBL29608298

SCHEMBL29608298

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.52
▸ MAPK9 P45984 1/20 0.52
▸ MAPK10 P53779 1/20 0.52
▸ NTSR1 P30989 8/20 0.52
▸ NTSR2 O95665 7/20 0.52
▸ SORT1 Q99523 5/20 0.52
▸ OPRD1 P41143 3/20 0.51
▸ REN P00797 1/20 0.51
▸ OPRM1 P35372 1/20 0.50
▸ OPRK1 P41145 1/20 0.50
▸ NMUR2 Q9GZQ4 1/20 0.49
▸ NMUR1 Q9HB89 1/20 0.49
▸ EPHA2 P29317 1/20 0.49
▸ AGTR1 P30556 1/20 0.49
▸ AGTR2 P50052 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29607740 0.94 MAPK8 (0.54) MAPK8MAPK9MAPK10NTSR1NTSR2
SCHEMBL31249422 0.91 MAPK8 (0.55) MAPK8MAPK9MAPK10NTSR1NTSR2
SCHEMBL29607872 0.90 MAPK8 (0.59) MAPK8MAPK9MAPK10NTSR1NTSR2
SCHEMBL31606963 0.89 MAPK8 (0.48) MAPK8MAPK9MAPK10NTSR1NTSR2
SCHEMBL29607286 0.89 MAPK8 (0.66) MAPK8MAPK9MAPK10REN
SCHEMBL30689267 0.89 OPRK1 (0.59) OPRM1OPRK1NMUR2NMUR1
SCHEMBL32679555 0.88 MAPK8 (0.50) MAPK8MAPK9MAPK10NTSR1NTSR2
SCHEMBL30272472 0.87 APLNR (0.57) MAPK8MAPK9MAPK10NTSR1NTSR2
SCHEMBL31384595 0.86 NPY4R (0.60) OPRM1OPRK1
SCHEMBL31384592 0.86 NPY4R (0.60) OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220120732-A1 TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2022-04-21 — — US disclosed
Send feedback